Dries De Wolf: Honored to Have Wolfgang Miesbach Comment on Our Latest Research
Dries De Wolf, Postdoctoral Researcher at the Institute of Regenerative Medicine (IREM), shared a post on LinkedIn:
“It is a true honor to have Wolfgang Miesbach write a commentary on our latest research paper in Blood Advances (American Society of Hematology).
The title of the commentary ‘Doing more with less in hemophilia B gene therapy’ perfectly addresses a central unsolved problem:
How to ensure that more patients reach a durably protective factor IX level – a problem we tried to solve by focusing on the transgene and extending the half-life of the gene therapy-derived factor IX.
Thank you, Wolfgang Miesbach.”
Title 1: Increased gene therapy efficacy through the use of extended half-life clotting factors
Authors: Dries De Wolf, Phuong Anh Nguyen, Nisha Nair, Fangye Gao, Venkata Anudeep Bheemsetty, Ermira Samara-Kuko, Marinee K. Chuah, Thierry VandenDriessche
Read the Full Article on Blood Advances
Title 2: Doing more with less in hemophilia B gene therapy
Authors: Wolfgang Miesbach
Read the Full Article on Blood Advances
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 28, 2026, 14:56Elizabeth Shirley: COVID-19 Vaccines, Spike Protein and Nitric Oxide Bioavailability
-
Oct 28, 2026, 14:39David Ledger: Anticoagulation Advances as Factor XIa Inhibition Reaches a New Milestone
-
Oct 28, 2026, 14:37Advancing Liver Health in Haemophilia Care – EAHAD
-
Oct 28, 2026, 14:34The Changing Landscape of Anticoagulant Therapy – ISTH
-
Oct 28, 2026, 14:17Clusterin Regulates von Willebrand Factor Multimer Stability Through ADAMTS13 Inhibition
-
Oct 28, 2026, 14:14Mina Jarrahi: Platelet-Rich Fibrin for Periodontal Regeneration
-
Oct 28, 2026, 14:06Mohammed Alo: A Stent Treats the Blockage, Not the Underlying Disease
-
Oct 28, 2026, 13:58Vladimir Lemaire: When Blood Clots Affect Elite Athletes
-
Oct 28, 2026, 13:27M. Alejandro Mosso-Pani: Dengue in Florida – Why Platelet Function Matters